Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT04464772 · ClinicalTrials.gov registry record

FreeStyle Libre Continuous Glucose Monitoring System Accuracy Study

A clinical trial of Diabetes Mellitus, sponsored by Abbott Diabetes Care.

Completed
Registry status
85
Enrollment target
4
Study locations

NCT04464772 is a study of Diabetes Mellitus that has completed, run by Abbott Diabetes Care. The registered enrollment target is 85 participants, below the 1,867-participant average among 208 other Diabetes Mellitus trials with a reported enrollment target (95% lower). The trial reports 4 study locations across 3 states.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT04464772, a study of Diabetes Mellitus, has completed, sponsored by Abbott Diabetes Care.

COMPLETED
Registry status
85 participants
Enrollment target
4
Study locations

Study Summary

The purpose of this study is to characterize the Freestyle Libre Glucose Monitoring System in pediatric and adult subjects with respect to YSI reference venous plasma sample measurements.

Conditions Studied

Interventions

  • DEVICE FreeStyle Libre 3

Study Locations (4)

California

  • AMCR Institute - Escondido
  • Sansum Diabetes Research Institute - Santa Barbara

Idaho

  • Rocky Mountain Diabetes & Osteoporosis Center - Idaho Falls

Washington

  • Rainier Clinical Research - Renton

Trial Details

FieldValue
Enrollment Target 85 participants
Start Date 2020-07-10
Est. Completion 2020-09-22

Sponsor

Abbott Diabetes Care

26 total trials

What the Registry Record Tells You About NCT04464772

The ClinicalTrials.gov registry entry for NCT04464772 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 85 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 1,867-participant average among 208 other Diabetes Mellitus trials with a reported enrollment target (95% lower). The listed sponsor is Abbott Diabetes Care, which has 26 total studies on file at ClinicalTrials.gov.

The record links to 1 condition, with Diabetes Mellitus appearing as the primary indexed condition, and to 1 intervention - of which FreeStyle Libre 3 is the first listed.

NCT04464772 reports 4 study locations spanning 3 distinct geographic areas - top geographies include California, Idaho, Washington.

Frequently Asked Questions

What is clinical trial NCT04464772 about?

NCT04464772 is a clinical study titled "FreeStyle Libre Continuous Glucose Monitoring System Accuracy Study". The purpose of this study is to characterize the Freestyle Libre Glucose Monitoring System in pediatric and adult subjects with respect to YSI reference venous plasma sample measurements.

What is the current status of trial NCT04464772?

This trial is currently completed. The enrollment target is 85 participants. The study started on 2020-07-10. Estimated completion is 2020-09-22.

What conditions does trial NCT04464772 study?

This clinical trial studies the following conditions: Diabetes Mellitus.

What interventions are being tested in trial NCT04464772?

The interventions under investigation include: FreeStyle Libre 3 (DEVICE).

Who is sponsoring clinical trial NCT04464772?

This trial is sponsored by Abbott Diabetes Care, which has 26 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT04464772 being conducted?

This trial has 4 study locations across California, Idaho, Washington. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Diabetes Mellitus

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.